scholarly journals Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk

2021 ◽  
Vol 8 ◽  
Author(s):  
Lucia Novelli ◽  
Ennio Lubrano ◽  
Vincenzo Venerito ◽  
Fabio Massimo Perrotta ◽  
Francesca Marando ◽  
...  

Psoriatic arthritis (PsA) is a chronic inflammatory disease primarily affecting peripheral and axial joints, with the possible presence of extra-articular manifestations (EAMs), such as psoriasis, uveitis, and inflammatory bowel disease. Recently, the concept of psoriatic disease (PsD) has been proposed to define a systemic condition encompassing, in addition to joints and EAMs, some comorbidities (e.g., metabolic syndrome, type II diabetes, hypertension) that can affect the disease outcome and the achievement of remission. EAMs and comorbidities in PsA share common immunopathogenic pathways linked to the systemic inflammation of this disease; these involve a broad variety of immune cells and cytokines. Currently, various therapeutics are available targeting different cytokines and molecules implicated in the inflammatory response of this condition; however, despite an improvement in the management of PsA, comprehensive disease control is often not achievable. There is, therefore, a big gap to fill especially in terms of comorbidities and EAMs management. In this review, we summarize the clinical aspects of the main comorbidities and EAMs in PsA, and we focus on the immunopathologic features they share with the articular manifestations. Moreover, we discuss the effect of a diverse immunomodulation and the current unmet needs in PsD.

Diabetes ◽  
1995 ◽  
Vol 44 (1) ◽  
pp. 1-10 ◽  
Author(s):  
R. C. Turner ◽  
A. T. Hattersley ◽  
J. T. Shaw ◽  
J. C. Levy

Author(s):  
Júlia Dias Magalhães ◽  
Camila Barreto dos Santos Tolomei ◽  
Roberta Santos Tunes ◽  
Urbino da Rocha Tunes ◽  
Márcia Tosta Xavier

Periodontitis and diabetes mellitus combine systemic condition and dental health and can cause  salivary alterations. This work examined the saliva of 16 individuals with type II diabetes mellitus (DM) and severe chronic periodontitis (SCP) (G1), 11 with DM and without SCP (G2), 14 without DM with SCP (G3) and 15 without DM and without SCP (G4). The periodontal condition was evaluated, salivary flow and buffering capacity were analyzed and salivary components were measured using commercial kits. Diabetics with SCP showed a tendency to decrease the flow. The buffering capacity remains unchanged. Urea (p < 0.018) and total protein (p < 0.001) were larger and less Calcium was observed (p < 0.0001) in diabetics. In patients with SCP, the DM favored even greater urea increase. The phosphate increased in groups G1, G2 and G3 (p < 0.0001) compared to G4. The metabolism from diabetics with SCP increases salivary proteins, increasing urea resulting from amino acids degradation by periodontal bacterias.


Lab on a Chip ◽  
2019 ◽  
Vol 19 (2) ◽  
pp. 241-253 ◽  
Author(s):  
Yunxiao Liu ◽  
Patthara Kongsuphol ◽  
Su Yin Chiam ◽  
Qing Xin Zhang ◽  
Sajay Bhuvanendran Nair Gourikutty ◽  
...  

Infiltration of immune cells into adipose tissue is associated with chronic low-grade inflammation in obese individuals.


2016 ◽  
Author(s):  
William P. Gilks

AbstractThere is long-standing evidence for gene-by-sex interactions in disease risk, which can now be tested in genome-wide association studies with participant numbers in the hundreds of thousands. Contemporary methods start with a separate test for each sex, but simulations suggest a more powerful approach should be to use sex as an interaction term in a single test. The traits currently with the most compelling evidence for sex-dependent genetic effects are for adiposity (predictive of cardiac disease), type II diabetes, asthma and inflammatory bowel disease. Sexually dimorphic gene expression varies dynamically, by age, tissue type, and chromosome, so sex dependent genetic effects are expected for a wide range of diseases.Key conceptsCompelling findings of sex-dependent genetic effects on disease have been made in adiposity-related anthropometric traits, type II diabetes, and inflammatory bowel disease. Other disorders remain to be more fully investigated, regardless of what sexual differences they exhibit in prevalence and presentation.Current evidence indicates that sex difference in gene expression is not required for a SNP to have a sex-dependent effect. However, sex differences in gene expression vary dynamically, by organ and age, so generalisations may be inaccurate without comprehensive data.Sex-dependent risk alleles are predicted to be of greater effect size than conventional ones, because natural selection acts only against the sex which has the disease. There is evidence for this from a high-powered GWAS of adiposity-related traits.Many of the large GWAS meta-analyses look for sex-dependent genetic effects by testing male and female groups separately. However, this may be under-powered compared to a whole-sample, gene-by-sex interaction test.GlossaryGenome-wide association study (GWAS). Method for identifying molecular genetic variation that controls heritable traits, in a population sample. Involves assessing the correlation between allele frequencies and phenotype value, at millions of markers of common genetic variation across the genome.Sexual dimorphism. A difference between males and females in a population for the value of a particular trait. May include anything from anatomical measurements to expression level of a gene.Sex-dependent genetic effect. A disease risk allele is termed sex-specific when it increases risk in one sex only but has no effect on the disease in the other sex. The term sex-biased is used for an allele causes a significant increase in risk of disease in both sexes, but for which the magnitude of the risk increase is significantly different between males and females. There are also reports where an allele that increases risk of a disease in one sex reduces risk of the same disease in the other sex but none have been replicated, and there is no biochemical reason why this could be true. It effectively constitutes a sexually antagonistic effect, but should be distinguished from intra-locus sexual conflict which explicitly requires than an allele have opposing effects on the evolutionary fitness of males and females (Bonduriansky and Chenoweth 2009). All of the above relationships constitute a form of sex-dependent genetic effect.


Author(s):  
Bakytgul Yermekbayeva ◽  
Togzhan Algazina ◽  
Madina Razbekova ◽  
Albert Pinhasov ◽  
Gulnar Batpenova ◽  
...  

Psoriasis is a chronic inflammatory disease characterized by skin lesions. Psoriasis development has been associated both with genetic and environmental factors. Though skin and gut microbiota has been implicated in number of pathologies including atopic dermatitis, inflammatory bowel disease, Crohn&rsquo;s disease, allergy, obesity, its role has been poorly studied in psoriatic disease, which incorporates both psoriasis and psoriatic arthritis. This literature review summarizes the most recent and major findings on microbiota features in psoriatic disease as well as gives immune system role in the given condition. Despite conflicting findings, psoriasis patients were frequently found to have distinct microbial composition in both skin and guts especially in the major bacterial phyla, Firmicutes, Bacteroidetes, and Akkermansia. Furthermore, bacterial DNA has been found in psoriatic patients both locally and systemically, and altogether suggesting role of bacteria in the chronic disease and future studies in this field.


2021 ◽  
Vol 17 (3) ◽  
pp. 475-485 ◽  
Author(s):  
Ez Alddin Rajjoub Al-Mahdi ◽  
Vivencio Barrios ◽  
Jose L Zamorano

Type II diabetes mellitus is a known cardiovascular risk factor and its prevalence continues to increase. A revolution in the Type II diabetes mellitus treatment has occurred with the arrival of new antidiabetic drugs, which are thought to compromise metformin place. We aim to review the pharmacology, available evidence and clinical aspects of metformin use in the era of new antidiabetics.


2021 ◽  
Vol 11 ◽  
Author(s):  
Qihang Hou ◽  
Jingxi Huang ◽  
Hammed Ayansola ◽  
Hori Masatoshi ◽  
Bingkun Zhang

The mammalian intestine is the largest immune organ that contains the intestinal stem cells (ISC), differentiated epithelial cells (enterocytes, Paneth cells, goblet cells, tuft cells, etc.), and gut resident-immune cells (T cells, B cells, dendritic cells, innate lymphoid cell, etc.). Inflammatory bowel disease (IBD), a chronic inflammatory disease characterized by mucosa damage and inflammation, threatens the integrity of the intestine. The continuous renewal and repair of intestinal mucosal epithelium after injury depend on ISCs. Inflamed mucosa healing could be a new target for the improvement of clinical symptoms, disease recurrence, and resection-free survival in IBD treated patients. The knowledge about the connections between ISC and immune cells is expanding with the development of in vitro intestinal organoid culture and single-cell RNA sequencing technology. Recent findings implicate that immune cells such as T cells, ILCs, dendritic cells, and macrophages and cytokines secreted by these cells are critical in the regeneration of ISCs and intestinal epithelium. Transplantation of ISC to the inflamed mucosa may be a new therapeutic approach to reconstruct the epithelial barrier in IBD. Considering the links between ISC and immune cells, we predict that the integration of biological agents and ISC transplantation will revolutionize the future therapy of IBD patients.


Diabetes ◽  
1995 ◽  
Vol 44 (1) ◽  
pp. 1-10 ◽  
Author(s):  
R. C. Turner ◽  
A. T. Hattersley ◽  
J. T. Shaw ◽  
J. C. Levy

Sign in / Sign up

Export Citation Format

Share Document